Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Exchange Rates
Interest Rates
Futures
Economy
Global Metrics

Cytori Therapeutics Inc Current Ratio 2006-2020 | PSTV

Cytori Therapeutics Inc current ratio from 2006 to 2020. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations.
  
Cytori Therapeutics Inc Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2020-03-31 $0.02B $0.02B 1.18
2019-12-31 $0.02B $0.01B 1.37
2019-09-30 $0.02B $0.01B 1.54
2019-06-30 $0.01B $0.01B 0.38
2019-03-31 $0.01B $0.02B 0.46
2018-12-31 $0.01B $0.02B 0.55
2018-09-30 $0.01B $0.02B 0.61
2018-06-30 $0.01B $0.02B 0.42
2018-03-31 $0.01B $0.02B 0.60
2017-12-31 $0.02B $0.02B 0.81
2017-09-30 $0.01B $0.02B 0.54
2017-06-30 $0.02B $0.01B 1.18
2017-03-31 $0.01B $0.01B 0.94
2016-12-31 $0.02B $0.01B 1.50
2016-09-30 $0.02B $0.01B 1.93
2016-06-30 $0.03B $0.01B 2.65
2016-03-31 $0.02B $0.01B 1.71
2015-12-31 $0.02B $0.01B 2.52
2015-09-30 $0.03B $0.01B 2.75
2015-06-30 $0.03B $0.01B 3.22
2015-03-31 $0.02B $0.02B 1.06
2014-12-31 $0.02B $0.02B 1.36
2014-09-30 $0.02B $0.01B 1.01
2014-06-30 $0.02B $0.02B 1.23
2014-03-31 $0.02B $0.02B 1.49
2013-12-31 $0.03B $0.02B 1.65
2013-09-30 $0.02B $0.01B 1.43
2013-06-30 $0.02B $0.01B 2.77
2013-03-31 $0.02B $0.02B 1.45
2012-12-31 $0.03B $0.02B 1.93
2012-09-30 $0.02B $0.02B 1.54
2012-06-30 $0.03B $0.01B 2.58
2012-03-31 $0.04B $0.01B 3.68
2011-12-31 $0.04B $0.01B 5.54
2011-09-30 $0.05B $0.01B 7.39
2011-06-30 $0.04B $0.02B 2.59
2011-03-31 $0.05B $0.02B 3.34
2010-12-31 $0.06B $0.01B 4.46
2010-09-30 $0.04B $0.01B 3.79
2010-06-30 $0.04B $0.01B 6.06
2010-03-31 $0.03B $0.01B 4.07
2009-12-31 $0.02B $0.01B 2.21
2009-09-30 $0.02B $0.01B 2.71
2009-06-30 $0.02B $0.01B 2.83
2009-03-31 $0.02B $0.01B 2.86
2008-12-31 $0.02B $0.01B 2.41
2008-09-30 $0.02B $0.01B 2.59
2008-06-30 $0.01B $0.01B 1.10
2008-03-31 $0.01B $0.01B 1.27
2007-12-31 $0.01B $0.01B 1.52
2007-09-30 $0.02B $0.01B 3.53
2007-06-30 $0.03B $0.01B 4.88
2007-03-31 $0.03B $0.01B 4.27
2006-12-31 $0.01B $0.01B 2.12
2006-09-30 $0.02B $0.01B 3.41
2006-06-30 $0.01B $0.01B 2.05
2006-03-31 $0.02B $0.01B 3.13
2005-12-31 $0.02B $0.01B 2.48
2005-09-30 $0.01B $0.01B 2.46
2005-06-30 $0.02B $0.00B 5.13
2005-03-31 $0.01B $0.00B 3.43
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.010B $0.007B
Plus Therapeutics Inc. is a clinical-stage pharmaceutical company. It engages in developing treatments for cancer and other diseases primarily in the United States. The company's product candidate consists of DocePLUS which are in clinical stage. Plus Therapeutics Inc., formerly known as Cytori Therapeutics Inc., is based in Austin, Texas.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $65.114B 36.95
Takeda Pharmaceutical (TAK) Japan $54.448B 9.54
Astellas Pharma (ALPMY) Japan $29.844B 0.00
Eisai (ESALY) Japan $24.126B 20.91
UCB SA (UCBJF) Belgium $23.749B 0.00
Merck (MKGAF) Germany $16.013B 0.00
Grifols, S.A (GRFS) Spain $12.761B 15.86
Catalent (CTLT) United States $12.084B 46.71
Neurocrine Biosciences (NBIX) United States $12.044B 55.66
Recordati Industria Chimica E Farmaceutica S.P.A (RCDTF) Italy $9.945B 0.00
Ono Pharmaceutical (OPHLF) Japan $9.254B 0.00
Ionis Pharmaceuticals (IONS) United States $8.650B 45.99
IPSEN SA ADR (IPSEY) France $7.290B 0.00
Orion OYJ (ORINY) Finland $7.077B 31.71
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.664B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $5.900B 9.44
United Therapeutics (UTHR) United States $5.169B 9.79
STADA ARZNEIMI (STDAF) Germany $4.916B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $4.530B 494.56
Nektar Therapeutics (NKTR) United States $4.276B 0.00
Evotec AG (EVTCY) Germany $4.040B 108.88
Hypermarcas (HYPMY) Brazil $3.840B 14.12
FibroGen (FGEN) United States $3.722B 0.00
ChemoCentryx (CCXI) United States $3.693B 0.00
PTC Therapeutics (PTCT) United States $3.600B 0.00
Taro Pharmaceutical Industries (TARO) Israel $2.492B 10.24
Pacira BioSciences (PCRX) United States $2.435B 49.83
Sage Therapeutics (SAGE) United States $2.228B 0.00
Cronos Group (CRON) Canada $2.205B 63.20
Corcept Therapeutics (CORT) United States $1.890B 18.74
Xencor (XNCR) United States $1.817B 0.00
USANA Health Sciences (USNA) United States $1.729B 17.74
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.677B 0.00
Ironwood Pharmaceuticals (IRWD) United States $1.571B 12.02
Akebia Therapeutics (AKBA) United States $1.561B 0.00
Indivior (INVVY) United States $1.523B 18.91
Zogenix (ZGNX) United States $1.507B 0.00
Heron Therapeutics (HRTX) United States $1.429B 0.00
Esperion Therapeutics (ESPR) United States $1.410B 0.00
Karyopharm Therapeutics (KPTI) United States $1.402B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $1.392B 15.00
Theravance Biopharma (TBPH) Cayman Islands $1.364B 0.00
CLINIGEN GP (CLIGF) United Kingdom $1.200B 0.00
Translate Bio (TBIO) United States $1.069B 0.00
Enanta Pharmaceuticals (ENTA) United States $1.024B 45.70
Tilray (TLRY) Canada $1.000B 0.00
BioCryst Pharmaceuticals (BCRX) United States $0.959B 0.00
Endo (ENDP) Ireland $0.790B 1.22
ImmunoGen (IMGN) United States $0.753B 0.00
Aerie Pharmaceuticals (AERI) United States $0.619B 0.00
Radius Health (RDUS) United States $0.618B 0.00
Trillium Therapeutics (TRIL) Canada $0.606B 0.00
VAXART, INC (VXRT) United States $0.592B 0.00
Molecular Templates (MTEM) United States $0.591B 0.00
Collegium Pharmaceutical (COLL) United States $0.574B 0.00
Ardelyx (ARDX) United States $0.571B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.557B 0.00
Catalyst Pharmaceuticals (CPRX) United States $0.511B 12.35
Crinetics Pharmaceuticals (CRNX) United States $0.502B 0.00
Innate Pharma SA (IPHYF) France $0.497B 0.00
BioSpecifics Technologies Corp (BSTC) United States $0.464B 18.11
Flexion Therapeutics (FLXN) United States $0.462B 0.00
Siga Technologies (SIGA) United States $0.462B 0.00
DURECT (DRRX) United States $0.412B 0.00
TherapeuticsMD (TXMD) United States $0.408B 0.00
Harpoon Therapeutics (HARP) United States $0.406B 0.00
Ocular Therapeutix (OCUL) United States $0.396B 0.00
Spectrum Pharmaceuticals (SPPI) United States $0.389B 0.00
Organogenesis Holdings (ORGO) United States $0.366B 0.00
Calithera Biosciences (CALA) United States $0.363B 0.00
MEI Pharma (MEIP) United States $0.352B 0.00
Altimmune (ALT) United States $0.347B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.300B 0.00
Concert Pharmaceuticals (CNCE) United States $0.299B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $0.298B 0.00
PROFOUND MEDICL (PROF) Canada $0.288B 0.00
Oasmia Pharmaceutical AB (OASMY) Sweden $0.248B 0.00
Taiwan Liposome (TLC) Taiwan $0.241B 0.00
Redhill Biopharma (RDHL) Israel $0.238B 0.00
CASI Pharmaceuticals (CASI) United States $0.235B 0.00
Lannett Co Inc (LCI) United States $0.232B 5.08
KalVista Pharmaceuticals (KALV) United States $0.220B 0.00
Rafael Holdings (RFL) United States $0.204B 0.00
Jounce Therapeutics (JNCE) United States $0.201B 4.80
OptiNose (OPTN) United States $0.189B 0.00
Nivalis Therapeutics (ALPN) United States $0.182B 0.00
IMV INC (IMV) Canada $0.182B 0.00
Nature's Sunshine Products (NATR) United States $0.181B 23.80
Aquestive Therapeutics (AQST) United States $0.144B 0.00
Otonomy (OTIC) United States $0.130B 0.00
Kitov Pharmaceuticals Holdings (KTOV) Israel $0.129B 0.00
La Jolla Pharmaceutical (LJPC) United States $0.118B 0.00
Champions Oncology (CSBR) United States $0.116B 0.00
ALLERGY THERAPT (AGYTF) United Kingdom $0.102B 0.00
Aptorum Group (APM) Hong Kong, SAR China $0.101B 0.00
Xeris Pharmaceuticals (XERS) United States $0.099B 0.00
Summit Therapeutics (SMMT) United Kingdom $0.099B 0.00
Recro Pharma (REPH) United States $0.098B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.096B 0.00
MediWound (MDWD) Israel $0.096B 0.00
Onconova Therapeutics (ONTX) United States $0.096B 0.00
CTI BioPharma (CTIC) United States $0.090B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.089B 0.00
Biomerica (BMRA) United States $0.088B 0.00
Sundial Growers (SNDL) Canada $0.087B 0.00
Heat Biologics (HTBX) United States $0.086B 0.00
AcelRx Pharmaceuticals (ACRX) United States $0.085B 0.00
Aclaris Therapeutics (ACRS) United States $0.083B 0.00
SCYNEXIS (SCYX) United States $0.070B 0.00
ASSERTIO THERAPEUTICS, INC (ASRT) United States $0.066B 0.00
Lipocine (LPCN) United States $0.064B 0.00
CV Sciences (CVSI) United States $0.061B 0.00
Addex Therapeutics (ADXN) Switzerland $0.057B 0.00
RENEURON GP (RNUGF) United Kingdom $0.057B 0.00
Infinity Pharmaceuticals (INFI) United States $0.056B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.048B 28.91
PolarityTE (PTE) United States $0.047B 0.00
Natural Alternatives (NAII) United States $0.046B 0.00
Entasis Therapeutics Holdings (ETTX) United States $0.043B 0.00
Adamis Pharmaceuticals (ADMP) United States $0.043B 0.00
Forward Pharma (FWP) Denmark $0.042B 0.00
Mannatechorporated (MTEX) United States $0.042B 7.87
Jaguar Animal Health (JAGX) United States $0.041B 0.00
Novan (NOVN) United States $0.041B 0.00
Opiant Pharmaceuticals (OPNT) United States $0.040B 86.09
Bellicum Pharmaceuticals (BLCM) United States $0.037B 0.00
GTx (ONCT) United States $0.034B 0.00
ElectroCore (ECOR) United States $0.032B 0.00
Neos Therapeutics (NEOS) United States $0.032B 0.00
Dipexium Pharmaceuticals (PLXP) United States $0.026B 0.00
Eyegate Pharmaceuticals (EYEG) United States $0.023B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
Flex Pharma (SLRX) United States $0.020B 0.00
Bio-Path Holdings (BPTH) United States $0.019B 0.00
ProPhase Labs (PRPH) United States $0.018B 0.00
Tetraphase Pharmaceuticals (TTPH) United States $0.018B 0.00
Regulus Therapeutics (RGLS) United States $0.017B 0.00
China SXT Pharmaceuticals (SXTC) China $0.015B 0.00
Cyanotech (CYAN) United States $0.014B 34.00
Shineco (TYHT) China $0.014B 0.00
RXi Pharmaceuticals (PHIO) United States $0.013B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.011B 0.00
HANCOCK JAFFE (HJLI) United States $0.009B 0.00
Vical (BBI) United States $0.009B 0.00
Midatech Pharma (MTP) United Kingdom $0.009B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
CannTrust Holdings (CTST) Canada $0.000B 0.00